Notizie eFFECTOR Therapeutics - EFTR

Ultime notizie

Data	Ora	Fonte	Titolo
21/2/2024	23:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/2/2024	23:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/2/2024	02:14	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
30/1/2024	14:31	EDGAR2	Form 8-K - Current report
26/1/2024	22:40	EDGAR2	Form 8-K - Current report
26/1/2024	22:32	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/2024	14:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/1/2024	14:01	EDGAR2	Form 8-K - Current report
08/1/2024	14:19	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/2024	14:15	EDGAR2	Form 8-K - Current report
08/12/2023	14:31	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
08/12/2023	14:23	EDGAR2	Form 8-K - Current report
28/11/2023	14:18	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
28/11/2023	14:15	EDGAR2	Form 8-K - Current report
13/11/2023	22:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/2023	22:23	EDGAR2	Form 8-K - Current report
11/9/2023	22:58	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/9/2023	22:51	EDGAR2	Form 8-K - Current report
08/8/2023	22:36	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/2023	22:25	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
08/8/2023	22:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/2023	22:08	EDGAR2	Form 8-K - Current report
04/8/2023	22:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/2023	22:02	EDGAR2	Form 8-K - Current report

Apertura: 2,19	Min: 2,10	Max: 2,26
Chiusura: 2,20